GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Cowealth Medical Holding Co 4745.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

10.25

-1.44%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Cowealth Medical Holding Co

Its shares trade on Taipei Exchange under the ticker 4745.TWO. It has been listed since 12 April 2013. In the fiscal year to 31 December 2025, it reported revenue of TWD 2.96bn and a net loss of TWD 246.6m. At that date it held total assets of TWD 7.04bn and shareholders' equity of TWD 2.87bn.

Cowealth Medical Holding Co., Ltd. engages in the manufacture and distribution of medical devices and products. The company is headquartered in George Town, Grand Cayman. The company went IPO on 2013-04-12. The firm's products include cancer treatment and medical testing equipment and reagents and supplies for clinical testing applications. The firm mainly distributes its products in China.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
12 Apr 2013

Leadership

Pay as last reported

  • Ms. Qiongzhi WangChairman of the Board, since 2006
  • Dun LiGeneral Manager, Director, since 2006
  • Liqing QiaoCorporate Governance Officer
  • Jing TianHead of Finance & Accounting
  • Guangjie CaoDirector
  • Baijian HuDirector
  • Mr. Quan JinDirector
  • Fengming YangDirector
  • Mr. Kun-Chih ChenIndependent Director
  • Shuhua ChenIndependent Director
  • Mr. Yingtong LouIndependent Director
  • Ms. Zongwen TongIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Headquartered in George Town, Grand Cayman.
  • Offers cancer treatment and medical testing equipment and reagents.
  • Distributes products primarily in China.

Weaknesses

  • No specific weaknesses mentioned in the provided information.
  • Limited geographic distribution beyond China.
  • No details on financial performance or market share provided.

Opportunities

  • Expansion into new markets outside China.
  • Growth in demand for medical devices and testing equipment.
  • Potential for partnerships with healthcare providers.

Threats

  • Dependence on the Chinese market for distribution.
  • Competition in the medical device industry.
  • Regulatory changes affecting medical products.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.